Rising incidence of diabetic foot ulcers, increasing rate of burn injuries, and growing geriatric population and high rate of injuries are some key factors driving market growth

The global wound care biologics market size is expected to reach USD 3.71 Billion by 2028 at a CAGR of 10.1%, according to the latest report by Reports and Data. Increasing incidence of chronic injuries such as diabetic foot ulcers and burn injuries, rising focus on advancement of treatment options, and growing burden of diseases across the globe are key factors expected to drive market revenue growth over the forecast period. In addition, increasing use of temporary skin substitutes and growing focus of pharmaceutical and biotechnology companies to develop advanced biologics are some other factors expected to contribute to revenue growth of the market going ahead.

Biologic wound healing therapies aim to accelerate the re-establishment of tissue repair mechanisms through the application of active biological agents that have antioxidant, antimicrobial, or anti-inflammatory attributes. Biologic dressings prevent water loss, heat loss, and protein and electrolyte loss and minimizes the risks of contamination. Wound care biologics accelerate wound closure and optimizes wound healing environment. Over the last decade, rapid advancement in understanding wounds and their pathophysiology have led to significant innovations in treatment of acute, chronic, and other wounds.

Growing incidences of burn injuries have increased the preference for wound care biologics as it enables rapid recovery with low-risk of contamination and zero complications. Rapid availability of superior quality biologics and growing investment to accelerate development of safe and high-quality wound care biologics are some other key factors expected to drive market growth over the forecast period. However, high costs associated with treatment and growing incidence of skin graft and substitute rejection are expected to hamper market growth to a certain extent over the forecast period.

Key companies profiled in the report include

Smith Nephew, Mölnlycke Health Care AB, Integra LifeSciences Corporation, Wright Medical, MiMedx Group, Vericel Corporation, Anika Therapeutics, Osiris Therapeutics, Organogenesis, Kerecis, Solsys Medical, ACell, Lavior Inc., and Marine Polymer Technologies, Inc.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/354

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Wound Care Biologics market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Order this Report @ https://www.reportsanddata.com/report-pricing/354

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Wound Care Biologics Market Segmentation based on Types:

Type Outlook (Revenue, USD Million; 2018–2028)

• Biologic Skin Substitutes
• Enzyme Based Formulations
• Growth Factors

Application Outlook (Revenue, USD Billion; 2018-2028)

• Acute Wounds
• Chronic Wounds
• Surgical Wounds

Some Key Highlights from the Report:

• Biologic skin substitutes segment is expected to account for largest revenue share in the global market over the forecast period owing to increasing preference for skin substitutes in treatment of chronic and severe wounds and their improved efficiency of wound closure.
• Ulcers segment revenue is expected to expand significantly over the forecast period owing to growing demand for wound care biologics due to increasing incidence of diabetic foot ulcers.
• North America accounted for the largest revenue share in the global market in 2020 and is expected to register significant revenue growth over the forecast period owing to rapid availability wide range of wound care biologics products, rising prevalence of diabetes and diabetic foot ulcers, and robust presence of key players in the region.

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/354

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com